Sponsor or institution
Clinical trials and research at 1ST Biotherapeutics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by 1ST Biotherapeutics, Inc. that are recruiting, at sites in 2 countries (most in South Korea (1), United States (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Evaluating the safety and tolerability of FB418 in healthy adults and elderly
This study is testing how safe and well-tolerated a new drug called FB418 is in healthy adults and older people by giving them single and multiple doses.
-
Investigating the safety and efficacy of FB849 for advanced solid tumors
This study is testing a new treatment called FB849, alone and with another drug, to see if it can help people with advanced solid tumors who don’t have other treatment options.
Quick answers
How many clinical trials run by 1ST Biotherapeutics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.